Sapphire Pharma will be attending the World Economic Forum 2025 in Davos, where global leaders converge to shape a healthier, more equitable future.

The World Economic Forum's annual meeting will be held in Davos, Switzerland from January 20-24th. It brings together change-makers, innovators, politicians, academics, experts, thought leaders, and industry figures to network, collaborate, and discuss solutions to urgent global challenges.

This year’s meeting will convene under theme of “Collaboration for the Intelligent Age” and encompasses 5 major priorities:

• Rebuilding Trust
• Reimagining Growth
• Investing in People
• Safeguarding the Planet
• Industries in the Intelligent Age

Sapphire Pharma's mission is to develop innovative therapies and ensure global access to critical treatments for infectious diseases, autoimmune disorders, and women’s health. This year, we’re focusing on malaria, which claimed 597,000 lives in 2023. We believe health equity means providing affordable, effective prevention and treatment to vulnerable populations.

At Davos, we’re driving forward:

• Enhancing Drug Development – Accelerating therapy delivery to patients
• Improving Access – Ensuring treatments reach underserved communities
• Optimizing Manufacturing – Lowering costs and innovating distribution to maximize impact

By working together, we can bridge the gap in malaria and other global health challenges, because health equity is not just a goal—it’s a responsibility.